Sep 1, 2026 07:02AM
Sep 1, 2026 07:02AM
Aug 6, 2026 07:02AM
Jul 29, 2026 07:03AM
Jul 29, 2026 07:01AM
May 5, 2026 08:34AM
May 5, 2026 08:32AM Ocugen Provides Business Update with First Quarter 2026 Financial Results
Apr 1, 2026 07:02AM
Apr 1, 2026 07:02AM
Mar 24, 2026 07:45AM
Mar 24, 2026 07:45AM
Mar 11, 2026 06:03AM
Mar 4, 2026 08:15AM
Mar 4, 2026 08:15AM Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
Mar 2, 2026 07:02AM
Mar 2, 2026 07:02AM
Jan 12, 2026 06:30AM
Jan 12, 2026 06:30AM
Nov 5, 2025 06:30AM
Sep 2, 2025 07:02AM
Sep 2, 2025 07:02AM Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
Aug 1, 2025 08:25AM
Jul 21, 2025 07:30AM
Jul 21, 2025 07:30AM
Jul 21, 2025 07:30AM
Jun 24, 2025 06:51AM
Jun 23, 2025 07:30AM
Jun 23, 2025 07:30AM Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
Jun 16, 2025 07:03AM
Jun 16, 2025 07:02AM
Jun 11, 2025 07:30AM
May 27, 2025 07:04AM
May 27, 2025 07:02AM
May 9, 2025 08:01AM
Mar 5, 2025 07:02AM Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results
Mar 3, 2025 09:01AM
Mar 3, 2025 09:00AM
Feb 27, 2025 08:48AM
Feb 27, 2025 08:46AM
Feb 12, 2025 07:45AM
Feb 12, 2025 07:42AM
Feb 3, 2025 06:31AM Ocugen (OCGN) Announces Positive Opinion of European Medicines Agency’s Committee for Advanced Therapies for Advanced Therapy Medicinal Product Classification for OCU400
Feb 3, 2025 06:30AM
Jan 27, 2025 06:31AM
Jan 27, 2025 06:30AM
Nov 20, 2024 07:33AM
Nov 20, 2024 07:30AM
Nov 8, 2024 06:45AM
Oct 22, 2024 07:02AM Ocugen (OCGN) Reports Data and Safety Monitoring Board Approves Initiation of Phase 2 of OCU410ST GARDian Clinical Trial for Stargardt Disease
Oct 22, 2024 07:02AM

329,910 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All